Recent studies reported that glioma cells expressing lineage markers such as A2B5 [32], NG2 [33], CD44 [29], and even GFAP also meet the criteria for tumorigenic stem cells, suggesting that GIC originate from a broader spectrum of neural lineages. This evidence concerns the gene CD44 and central nervous system cancer.